IP Library Granted Patent US 11,587,672
Granted Patent B1
US 11,587,672 · App. 16/537,366 · Granted Feb 21, 2023

Tiered time-in-range guiding interfaces for diabetes management

Inventors: Nikhil Roy (Sunnyvale, CA); Howard Zisser (Santa Barbara, CA)
Assignee: Verily Life Sciences LLC
G16H40/63A61B5/0002A61B5/0022A61B5/14532A61B5/4842A61B5/7282A61B5/743A61B5/7475G16H10/60A61B5/7275A61B5/746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,587,672
App. No.
16/537,366
Granted
Feb 21, 2023
Kind
B1
Abstract

Introduced here are diabetes management platforms able to guide people with diabetes toward a glycemic target. Rather than state the absolute amount of glucose within the blood, the diabetes management platform can instead produce personalized glycemic goals based on the physiological data associated with an individual. For example, if the diabetes management platform determines that the time spent within a first glycemic range exceeds a specified threshold, then the diabetes management platform may recommend that the individual attempt to keep their blood glucose level within a second glycemic range. Generally, the second glycemic range is closer than the first glycemic range to a target glycemic range corresponding to a healthy glycemic state.

Claims (42)

1. A computer-implemented method comprising:

acquiring, by a processor, data generated by a glucose monitoring device that monitors a blood glucose level of an individual over successive time intervals;

identifying, by the processor, a cohort of which the individual is a member; and

for each time interval of the successive time intervals,

calculating, by the processor, a time-in-range (TIR) measure indicative of a duration during which the blood glucose level was within a corresponding glycemic range defined by a first lower bound and a first upper bound;

determining, by the processor, that the TIR measure exceeds a threshold;

identifying, by the processor, an appropriate glycemic range for a next time interval based on the corresponding glycemic range,

wherein the appropriate glycemic range is defined by a second lower bound and a second upper bound that is lower than the first upper bound, and

wherein a difference between the first and second upper bounds is based on success of other members of the cohort in lowering respective glycemic ranges; and

causing, by the processor, a notification to be presented by an electronic device associated with the individual,

wherein the notification specifies that the blood glucose level is expected to remain within the appropriate glycemic range during the next time interval, such that the individual is progressively guided toward a target glycemic range indicative of a healthy glycemic state.

2. The computer-implemented method of claim 1 , wherein the appropriate glycemic range corresponds to the target glycemic range to a larger degree than the corresponding glycemic range.

3. The computer-implemented method of claim 1 , wherein the second lower bound is lower than the first lower bound.

4. The computer-implemented method of claim 1 , wherein the second lower bound is higher than the first lower bound.

5. The computer-implemented method of claim 1 , wherein the corresponding glycemic range and the appropriate glycemic range at least partially overlap.

6. The computer-implemented method of claim 1 , further comprising:

generating, by the processor, a graphical representation that visually depicts directionality of the blood glucose level over time,

wherein the graphical representation identifies the appropriate glycemic ranges identified for the successive time intervals.

7. The computer-implemented method of claim 6 , wherein the graphical representation further identifies the target glycemic range indicative of the healthy glycemic state.

8. The computer-implemented method of claim 1 , further comprising:

for each time interval of the successive time intervals,

storing, by the processor, information representative of the corresponding glycemic range, the TIR measure, or the appropriate glycemic range in a profile associated with the glucose monitoring device and the electronic device.

9. The computer-implemented method of claim 1 , wherein members of the cohort share a health-related characteristic in common.

10. The computer-implemented method of claim 9 , wherein the health-related characteristic is race, age, sex, medication regimen, or diabetes type.

11. A non-transitory computer-readable medium with instructions stored thereon that, when executed by a processor, cause the processor to perform operations comprising:

acquiring data generated by a glucose monitoring device responsible for monitoring a blood glucose level of an individual over successive time intervals;

identifying a cohort of which the individual is a member; and

for each time interval of the successive time intervals,

calculating a time-in-range (TIR) measure indicative of a duration during which the blood glucose level was within a corresponding glycemic range defined by a first upper bound and a first lower bound;

comparing the TIR measure to a first threshold representative of a percentage of that time interval;

identifying, based on an outcome of said comparing, an appropriate glycemic range for a next time interval,

wherein the appropriate glycemic range is defined by a second upper bound and a second lower bound that are determined based on the first glycemic range, and

wherein a difference between the first and second upper bounds and/or the first and second lower bounds is based on success of other members of the cohort in lowering respective glycemic ranges; and

causing display of a notification that specifies the blood glucose level is expected to remain within the appropriate glycemic range during the next time interval, such that gradually lowering or narrowing glycemic ranges are successively presented to the individual.

12. The non-transitory computer-readable medium of claim 11 , wherein the operations further comprise:

receiving input that specifies the second upper bound and/or the second lower bound.

13. The non-transitory computer-readable medium of claim 11 ,

wherein the outcome of said comparing is a determination that the TIR measure exceeds the first threshold, and

wherein the second upper bound is lower than the first upper bound.

14. The non-transitory computer-readable medium of claim 11 ,

wherein the outcome of said comparing is a determination that the TIR measure does not exceed the first threshold, and

wherein the second upper bound is identical to the first upper bound and/or the second lower bound is identical to the first lower bound.

Assignments (2)
CHANGE OF NAME Recorded Apr 21, 2026
From: VERILY LIFE SCIENCES LLC
To: VERILY HEALTH INC.
Reel/Frame 075477/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2019
From: ROY, NIKHIL; ZISSER, HOWARD
To: VERILY LIFE SCIENCES LLC
Reel/Frame 050910/0502 →